Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19189020 | System and Method for Emotionally Intelligent, Personalized AI Avatar-Based Health Coaching Using Multi-Domain Data and Adaptive Behavioral Intelligence | April 2025 | October 2025 | Allow | 6 | 1 | 1 | Yes | No |
| 19189035 | System and Method for Emotionally Intelligent, Personalized AI Avatar-Based Health Coaching Using Multi-Domain Data and Adaptive Behavioral Intelligence | April 2025 | October 2025 | Allow | 5 | 1 | 0 | Yes | No |
| 18864504 | REMOTE SCANNING AND VALIDATING OF CLINICAL ORDER DEVICE CONFIGURATIONS | November 2024 | March 2025 | Allow | 4 | 0 | 0 | No | No |
| 18815981 | SYSTEM AND METHOD FOR DETERMINING A PERSONALIZED PROBIOTIC THERAPEUTIC REGIMEN | August 2024 | January 2026 | Allow | 17 | 1 | 0 | No | No |
| 18839946 | MEDICAL IMAGING DEVICE, MEDICAL SYSTEM, METHOD FOR OPERATING A MEDICAL IMAGING DEVICE, AND METHOD FOR MEDICAL IMAGING | August 2024 | January 2026 | Allow | 16 | 2 | 0 | Yes | No |
| 18714009 | REMOTE IMAGE DIAGNOSIS COMPREHENSIVE SUPPORT APPARATUS, METHOD OF COMPREHENSIVE SUPPORT FOR REMOTE DIAGNOSTIC IMAGING AND PROGRAM | May 2024 | June 2025 | Abandon | 13 | 1 | 0 | No | No |
| 18685962 | METHODS AND SYSTEMS FOR COMMUNICATION BETWEEN SONOGRAPH USERS AND RADIOGRAPH INTERPRETERS | February 2024 | January 2026 | Allow | 22 | 2 | 0 | No | No |
| 18433212 | Optimizing Data Flow and Display in an Electronic Medical Records (EMR) System | February 2024 | October 2025 | Allow | 21 | 0 | 0 | Yes | No |
| 18430785 | SYSTEMS AND METHODS TO PROCESS ELECTRONIC IMAGES TO PROVIDE AUTOMATED ROUTING OF DATA | February 2024 | April 2025 | Allow | 14 | 1 | 0 | Yes | No |
| 18369983 | SYSTEMS AND METHODS TO SELECT AND SHARE LEARNING CONTENT BASED ON SIMILAR ACTIVITIES | September 2023 | January 2026 | Abandon | 28 | 1 | 0 | No | No |
| 18230482 | SYSTEMS AND METHODS FOR TRACKING ITEMS | August 2023 | October 2025 | Allow | 27 | 1 | 0 | No | No |
| 18359073 | ORDER ASSIGNMENT METHOD FOR DENTAL RESTORATIONS | July 2023 | November 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18221795 | Combining Dietary Recommendations Across Comorbidities | July 2023 | September 2025 | Abandon | 26 | 1 | 0 | Yes | No |
| 18340374 | PATIENT ASSURANCE SYSTEM AND METHOD | June 2023 | July 2025 | Allow | 25 | 1 | 0 | No | No |
| 18312434 | MEDICAL AND HEALTHCARE SERVICE PLATFORMS AND USES THEREOF | May 2023 | December 2025 | Allow | 31 | 2 | 0 | No | No |
| 18308247 | SYSTEM FOR INDUCING SONOPORATION OF A DRUG INTO CANCER CELLS AND METHOD THEREOF | April 2023 | May 2025 | Allow | 25 | 1 | 0 | Yes | No |
| 18300455 | Data Services Modeling and Manager for Transformation and Contextualization of Data in Automated Performance of Workflows | April 2023 | October 2025 | Allow | 30 | 2 | 0 | No | No |
| 18165675 | MEDICAL DEVICE CALIBRATION | February 2023 | April 2025 | Allow | 26 | 3 | 0 | Yes | No |
| 18077490 | FIELD KIT FOR A DEATH SCENE INVESTIGATION | December 2022 | October 2025 | Allow | 34 | 2 | 0 | Yes | No |
| 17935783 | POPULATION HEALTH PLATFORM | September 2022 | June 2025 | Abandon | 32 | 1 | 0 | No | No |
| 17940422 | DEVICES AND METHODS FOR ASSISTING A USER OF A DRUG DELIVERY DEVICE | September 2022 | June 2025 | Abandon | 33 | 5 | 0 | No | Yes |
| 17929983 | METHOD AND APPARATUS FOR INTELLIGENT PHARMACOVIGILANCE PLATFORM | September 2022 | October 2025 | Allow | 37 | 2 | 0 | No | No |
| 17864166 | METHODS FOR TRACKING AND RESPONDING TO MENTAL HEALTH CHANGES IN A USER | July 2022 | May 2025 | Abandon | 34 | 1 | 0 | No | No |
| 17849496 | SYSTEMS AND METHODS FOR CLASS OF TRADE RECOMMENDATIONS FOR A HEALTHCARE SITE | June 2022 | March 2025 | Allow | 33 | 1 | 0 | No | No |
| 17830586 | THERAPY MANAGEMENT SYSTEM | June 2022 | February 2025 | Abandon | 32 | 2 | 0 | No | No |
| 17748170 | TELEHEALTH CONTROL SYSTEM AND METHOD | May 2022 | May 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17755110 | SYSTEMS AND METHODS FOR NUTRIENT SCORING ACCORDING TO LABELLED NUTRIENTS ON A FOOD OR BEVERAGE PRODUCT | April 2022 | April 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17724395 | CEREBRAL HEMORRHAGE ANALYSIS IN CT IMAGES | April 2022 | March 2025 | Abandon | 35 | 1 | 0 | No | No |
| 17720965 | IMAGE PROCESSING APPARATUS AND METHOD FOR CONTROLLING THE SAME | April 2022 | April 2025 | Allow | 36 | 2 | 0 | No | No |
| 17575855 | HEALTH DATA PROCESSING SYSTEM AND HEALTH DATA PROCESSING METHOD | January 2022 | April 2025 | Abandon | 39 | 2 | 0 | No | No |
| 17647613 | SUBPOPULATION BASED PATIENT RISK PREDICTION USING GRAPH ATTENTION NETWORKS | January 2022 | April 2025 | Allow | 39 | 3 | 0 | No | No |
| 17554714 | METHODS AND SYSTEMS FOR CONVERTING UNSTRUCTURED DATA INTO AN ENCODED, STRUCTURED REPRESENTATION | December 2021 | February 2025 | Allow | 38 | 2 | 0 | No | No |
| 17552314 | SYSTEMS AND METHODS FOR ESTIMATING A NET HEALTH CARE DEMAND OF POTENTIAL PATIENTS IN ONE OR MORE GEOGRAPHIC AREAS | December 2021 | March 2025 | Allow | 39 | 3 | 0 | Yes | No |
| 17643363 | SYSTEMS AND METHODS FOR MONITORING AND MANAGING NEUROLOGICAL DISEASES AND CONDITIONS | December 2021 | October 2024 | Allow | 34 | 1 | 0 | Yes | No |
| 17540991 | USER INTERFACES RELATED TO CLINICAL DATA | December 2021 | March 2025 | Allow | 39 | 2 | 0 | Yes | No |
| 17530435 | RADIOLOGY PEER REVIEW USING ARTIFICIAL INTELLIGENCE WITH REVIEW FEEDBACK | November 2021 | May 2025 | Abandon | 42 | 3 | 0 | Yes | No |
| 17530434 | RADIOLOGY PEER REVIEW USING ARTIFICIAL INTELLIGENCE | November 2021 | April 2025 | Abandon | 41 | 3 | 0 | Yes | No |
| 17508541 | METHODS AND SYSTEM FOR HEMORRHAGE-SPECIFIC DETERMINATIONS | October 2021 | August 2024 | Allow | 34 | 1 | 0 | Yes | No |
| 17305830 | Systems and Methods for an Artificial Intelligence System | July 2021 | April 2025 | Allow | 45 | 4 | 0 | Yes | No |
| 17364568 | SYSTEM AND METHOD FOR EMERGENCY MEDICAL EVENT CAPTURE, RECORDING AND ANALYSIS WITH GESTURE, VOICE AND GRAPHICAL INTERFACES | June 2021 | January 2025 | Allow | 43 | 3 | 0 | Yes | No |
| 17362792 | METHOD FOR DISPLAYING AN EARLY WARNING SCORE, MONITORING DEVICE AND DISPLAY SYSTEM | June 2021 | March 2025 | Allow | 45 | 3 | 0 | Yes | No |
| 17157218 | CLINICAL PREDICTIVE ANALYTICS SYSTEM | January 2021 | February 2025 | Allow | 49 | 3 | 0 | No | No |
| 17138363 | Medication Adherence Device And Coordinated Care Platform | December 2020 | December 2024 | Allow | 47 | 3 | 0 | Yes | No |
| 16949785 | AUTOMATIC CONTENT TAGGING IN VIDEOS OF MINIMALLY INVASIVE SURGERIES | November 2020 | May 2025 | Allow | 54 | 3 | 1 | Yes | No |
| 17097344 | AUTOMATED SYSTEM FOR ERROR CHECKING INJECTION PARAMETERS DURING IMAGING EXAMS | November 2020 | December 2024 | Allow | 49 | 3 | 0 | No | No |
| 16769647 | AN APPARATUS AND METHOD FOR PERSONALIZED MEAL PLAN GENERATION | June 2020 | November 2024 | Abandon | 53 | 4 | 0 | Yes | No |
| 16847043 | Electronic Devices and Methods for Treating Depressive Symptoms Associated With Multiple Sclerosis | April 2020 | February 2025 | Abandon | 58 | 4 | 0 | Yes | Yes |
| 16678234 | TECHNIQUES FOR IMAGE-BASED EXAMINATION OF DIALYSIS ACCESS SITES | November 2019 | October 2025 | Abandon | 60 | 6 | 0 | Yes | Yes |
| 16442277 | POPULATION HEALTH PLATFORM | June 2019 | May 2020 | Allow | 11 | 2 | 0 | Yes | No |
| 13450138 | SYSTEM AND METHOD FOR CREATING AND MANAGING THERAPEUTIC TREATMENT PROTOCOLS WITHIN TRUSTED HEALTH-USER COMMUNITIES | April 2012 | April 2016 | Abandon | 48 | 11 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BLANCHETTE, JOSHUA B.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner BLANCHETTE, JOSHUA B works in Art Unit 3684 and has examined 19 patent applications in our dataset. With an allowance rate of 68.4%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 45 months.
Examiner BLANCHETTE, JOSHUA B's allowance rate of 68.4% places them in the 30% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by BLANCHETTE, JOSHUA B receive 3.37 office actions before reaching final disposition. This places the examiner in the 92% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by BLANCHETTE, JOSHUA B is 45 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a -37.5% benefit to allowance rate for applications examined by BLANCHETTE, JOSHUA B. This interview benefit is in the 0% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 23.9% of applications are subsequently allowed. This success rate is in the 34% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 2% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 74% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.